Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board
San Diego, California--(Newsfile Corp. - November 27, 2023) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for unmet pediatric diseases, today announced the addition of Vincent Stanton Jr., MD to its Scientific Advisory Board ("SAB"). Dr. Stanton was a co-founder of Thiogenesis Therapeutics, Inc., dating back to February 2016.Dr. Vincent Stanton Jr., MD i...
San Diego United States Vincent Stanton Jr Company Filing Statement Dana Farber Cancer Institute Venture Exchange
Source: yahoo.com